Mason, MA;
Paredes, CG;
Papadopoulou, AS;
Bates, GP;
(2018)
A04 The role of splicing factor SRSF6 in incomplete splicing of the HTT transcript.
In:
(Proceedings) Plenary Meeting of the European-Huntington's-Disease-Network (EHDN).
(pp. A1-A2).
BMJ Publishing Group
Preview |
Text
Bates_THE ROLE OF SPLICING FACTOR SRSF6 IN INCOMPLETE SPLICING OF THE HTT TRANSCRIPT.pdf - Accepted Version Download (111kB) | Preview |
Abstract
Background Huntington’s disease (HD) is caused by an expanded CAG repeat in exon 1 of the HTT gene. In models of HD, an expanded CAG repeat in HTT causes premature termination of HTT RNA during transcription; this occurs by a process called incomplete splicing. Incompletely spliced HTT (HTTexon1) includes exon 1 of the coding region of HTT, as well as a 5’ region of intron 1, which is non-coding. HTTexon1 encodes a truncated exon 1 HTT protein, which is implicated in HD pathogenesis. Although the precise RNA processing mechanism of Httexon1 is unknown, splicing factor SRSF6 has been shown to co-precipitate with transcripts containing Htt intron 1 in HD mice. Aim To elucidate the role of splicing factor SRSF6 in incomplete splicing of Htt in HD mice. Methods Heterozygous Srsf6 knock-out (KO) mice (Srsf6±) were generated by CRISPR/Cas9. Characterisation of Srsf6± mice was undertaken by quantitative RT-PCR and western blotting. Viability of homozygous Srsf6 KO (Srsf6-/-) mice was examined by inbreeding of Srsf6± mice. To assess the modulation of incomplete splicing by decreasing SRSF6, Srsf6± mice were bred to HD knock in mice (zQ175) and tissues were analysed. Levels of Httexon1 were measured by Quantigene, a gene expression assay. Results Srsf6-/- homozygotes were embryonic lethal, limiting us to the use of Srsf6± mice only. In Srsf6± heterozygotes, Srsf6 mRNA was decreased by 50% in brain and peripheral regions, and SRSF6 protein was decreased by 70% in brain compared to wild type mice. However, heterozygosity for Srsf6 knock out did not modulate the level on incomplete splicing in zQ175 mice. Conclusion Ablation of a single Srsf6 allele did not reduce levels of incomplete splicing in HD mice and therefore, further Srsf6 knock down may be required. Accordingly, mouse embryonic fibroblasts (MEFs) have been generated and will be used to measure Httexon1 levels after further Srsf6 knockdown by RNA interference. This work is supported by the CHDI foundation.
| Type: | Proceedings paper |
|---|---|
| Title: | A04 The role of splicing factor SRSF6 in incomplete splicing of the HTT transcript |
| Event: | Plenary Meeting of the European-Huntington's-Disease-Network (EHDN) |
| Location: | Vienna, AUSTRIA |
| Dates: | 2018 - 2018 |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/jnnp-2018-EHDN.4 |
| Publisher version: | https://doi.org/10.1136/jnnp-2018-EHDN.4 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Psychiatry, Surgery, Neurosciences & Neurology |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10097495 |
Archive Staff Only
 |
View Item |
